# Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial

> **NCT00110448** · PHASE4 · COMPLETED · sponsor: **Kumamoto University** · enrollment: 2539 (actual)

## Conditions studied

- Coronary Disease
- Arteriosclerosis
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Aspirin
- **DRUG:** No aspirin

## Key facts

- **NCT ID:** NCT00110448
- **Lead sponsor:** Kumamoto University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-12
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 2539 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00110448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00110448, "Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00110448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*